Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EE.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BW.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.42.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDYSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDRSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used